| x | ANNUAL  REPORT  UNDER  SECTION      13 OR 15(d) OF THE  SECURITIES  EXCHANGE ACT OF      1934 |
|---|-------------------------------------------------------------------------------------------------------------------------------------------------|

|  ̈ | TRANSITION      REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES  EXCHANGE ACT      OF 1934 |
|--------|---------------------------------------------------------------------------------------------------------|

| Nevada                                                                  |   | 333-141384                 |   | 98-0517550                            |
|-------------------------------------------------------------------------|--------|----------------------------|--------|---------------------------------------|
| (State      or other jurisdiction ofincorporation      or organization) |   | (Commission      File No.) |   | (IRS      Employee IdentificationNo.) |

| Title of Each Class:                |   | Name of Each Exchange on Which Registered |
|----------------------------------------------------|--------|-------------------------------------------------------------------------|
| Common Stock, par value $0.001 |   | None                                                                    |

| Large accelerated filer  ̈ | Accelerated filer  ̈ | Non-accelerated filer  ̈(Do not check if a smallerreporting company) | Smaller reportingcompany þ |
|-----------------------------------------------|------------------------------------|------------------------------------------------------------------------------------------------------------------|-------------------------------------------|

----

| Number        |   | Description of Exhibit                                                                                                                                                                                                                                                                                                                                    |
|---------------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 3.1           |   | Amended      and Restated Articles of Incorporation of the Company incorporated by      reference to exhibit 1 of Form 8-A12G filed on April 13,    2009                                                                                                                                                                                                            |
| 3.2           |   | Amended      and Restated Bylaws of the Company incorporated by reference to exhibit 2      of Form 8-A12G filed on April 13, 2009.                                                                                                                                                                                                                                 |
| 4.1      (1)  |   | Stock      Purchase Agreement by and among Aspen Racing Stables, Inc., Trixy      Sasyniuk-Walt, Kun Run Biotechnology Ltd., Xueyun Cui and Liqiong Yang      dated August 21, 2008                                                                                                                                                                                 |
| 4.2      (1)  |   | Make      Good Escrow Agreement by and among Aspen Racing Stables, Inc., Xueyun Cui,      Trixy Sasyniuk-Walt, and Securities Transfer Corporation dated September      16, 2008                                                                                                                                                                                    |
| 10.1      (1) |   | Consulting      Agreement by and between Halter Capital Corporation and Kun Run      Biotechnology Ltd. dated September 16, 2008                                                                                                                                                                                                                                    |
| 10.2      (2) |   | Real      Property Purchase and Sale Agreement between Hainan Zhonghe Pharmaceutical      Co., Ltd. and Hainan Twenty First Media Co., Ltd. dated October 9,      2008                                                                                                                                                                                              |
| 10.3      (2) |   | Supplemental      Contract to exhibit 10.2 dated October 27, 2008                                                                                                                                                                                                                                                                                                   |
| 10.4      (2) |   | Real      Property Purchase and Sale Agreement between Hainan Zhonghe Pharmaceutical      Co., Ltd. and Hainan Xike Real Estates Co., Ltd. dated October 6,      2008                                                                                                                                                                                               |
| 10.5      (2) |   | Power      Cable Purchase Agreement between Hainan Zhonghe Pharmaceutical Co. Ltd.      and Hainan Delixi Electric Power Facility Company dated March 27,      2008                                                                                                                                                                                                 |
| 10.6      (2) |   | Power      Cable Purchase Agreement between Hainan Delixi Electro-mechanical      Equipment Mfg.Co.Ltd and Hainan Zhonghe Pharmaceutical Co. Ltd. dated      March 27, 2008                                                                                                                                                                                         |
| 10.7      *   |   | General      Agent Agreement between Hainan Zhonghe Pharmaceutical Co. Ltd. and Beijing      Yabaofangda Pharmaceutical Limited dated November 1, 2008 (certain      portions of the exhibit have been omitted based upon a request for      confidential treatment and the non-public information has been filed with      the Securities and Exchange Commission) |
| 10.8      (2) |   | Employment      Agreement between the Company and Yan Lin dated January 1,      2009                                                                                                                                                                                                                                                                                |
| 10.9      (2) |   | Employment      Agreement between the Company and Xiaoqun Ye dated January 1,      2007                                                                                                                                                                                                                                                                             |
| 21.1          |   | Subsidiaries      of the Company (incorporated by reference to same exhibit number of our      annual report on Form 10-K/A filed on April 3, 2009)                                                                                                                                                                                                                 |
| 31.1*         |   | Certification      of Chief Executive Officer under Section 302 of the Sarbanes-Oxley Act of      2002                                                                                                                                                                                                                                                              |
| 31.2*         |   | Certification      of Principal Financial Officer under Section 302 of the Sarbanes-Oxley Act      of 2002                                                                                                                                                                                                                                                          |
| 32.1*         |   | Certifications      Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C.      Section 1350                                                                                                                                                                                                                                                          |

----

|                            | Kun      Run Biotechnology, Inc. |
|---------------------------------|----------------------------------|
|                            | (Registrant)                |
|                            |                             |
|  Dated:      July 30, 2009 |                             |
|                            | By       /s/ Xiaoqun Ye     |
|                            | Name:                            | Xiaoqun      Ye |
|                            | Title:                           | Chief      Executive Officer |

| Signature                |   | Title                         |
|--------------------------|--------|-------------------------------|
|                     |   |                          |
| /s/      Xueyun      Cui |   | Director                      |
| Xueyun      Cui          |   |                          |
|                     |   |                          |
| /s/Yan Lin               |   | Chief      Accounting Officer |
| Yan      Lin             |   |                          |

----